Exhale

The official blog of the Lung Institute.

Resveratrol May Help Reduce Lung Inflammation

24 Oct 2017
| Under Disease Education | Posted by
| 10 Comments
Resveratrol_May_Help_Reduce_Lung_Inflammation_Blog-FB

COPD and other chronic lung disease sufferers are always looking for anything that might make their lives a little more manageable. It might be the next best drug treatment, it might be a new breathing technique or even the latest natural remedy.

For a number of years, the natural compound resveratrol has been known to have anti-inflammation properties. Resveratrol is found abundantly in many foods such as grapes and, by association, red wine, and also in peanuts, blueberries and other berries. It was initially touted as helping life extension, heart health, obesity, muscle growth and some cancer prevention.

But, a recent study by researchers at Georgia State University found it can alleviate inflammation in airway diseases. Those diseases include chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, pulmonary fibrosis, interstitial lung disease, pneumoconiosis, and bronchiectasis.

While researchers note they are not sure how it suppresses inflammation, it definitely works to protect the body against damage. The researchers said traditional drugs like inhalers, nebulizers and corticosteroids lose their effectiveness over time due to increasing numbers of antibiotic-resistant strains, while resveratrol does not show any signs of losing its effectiveness.

While resveratrol is a natural ingredient of red wine, doctors still advise drinking it in moderation – no more than 1-2 drinks in one sitting. Resveratrol can also be purchased as a supplement in pill form.

It is important to remember that drugs and supplements such as resveratrol, only help a person with lung disease manage their symptoms.  The Lung Institute is one of the only treatment options to address this disease, short of a full lung transplant.

If you or someone you know suffers from a chronic disease like ILD, COPD, pulmonary fibrosis or other symptoms of lung disease, the Lung Institute may be able to help with a variety of cellular treatment options. Contact us today at (800) 729-3065 to see if you qualify for cellular therapy, and find out what cellular therapy could mean for you.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.